Journal of Atherosclerosis and Thrombosis

简称 J ATHEROSCLER THROMB ·JAPAN ·出版周期 Bimonthly ·年均收录 117 篇

2.8

最新影响因子

23.20%

自引率

约75%

投稿难度

平均1月

审稿周期

期刊简介

Journal of Atherosclerosis and Thrombosis是一本专注于动脉粥样硬化和血栓形成研究的学术期刊，ISSN号为1340-3478，由日本动脉硬化学会出版，出版地为日本，出版周期为月刊。该期刊由Japan Atherosclerosis Society发行，最新影响因子约为3.5，属于SCI收录期刊，在中科院分区中通常位于医学类3区或4区，非完全开放获取（OA）期刊。其发文特点集中于动脉粥样硬化、血栓形成、脂质代谢、心血管疾病及相关基础与临床研究，尤其关注亚洲人群的流行病学与治疗进展。杂志质量较高，审稿严谨，但投稿竞争较激烈，接收率中等，需注意研究创新性和方法学严谨性，无明显学术风险，适合心血管领域研究者投稿。

影响因子趋势

近期发表

A Literature Review on the Waist Circumference Criteria for Metabolic Syndrome in Japan: Evidence and Implications for Cardiovascular Risk Stratification 2026-08-02

It’s Time to Measure Lp(a): Recognizing a Neglected Cardiovascular Risk 2026-05-08

A Phase 1 Study Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Zerlasiran in Japanese Participants 2026-05-07

Cross-Sectional Association of Lipoprotein(a) Levels With Vascular Complications and Related Parameters in a Japanese Type 2 Diabetes Cohort 2026-05-20

Major Bleeding During Factor Xa Inhibitor Therapy: Lessons from the Pre-Andexanet Era in Japan 2026-07-07

Association Between Plasma Omega-3 and Omega-6 Fatty Acid Levels and Atrial Fibrillation: A Large-Scale, Real-World Retrospective Study in Japan 2026-05-18

Intracranial Arterial Stenosis beyond Atherosclerosis: Insights from <i>RNF213</i> 2026-06-02

Current and Future Perspectives of LDL-C Lowering Therapies 2026 2026-05-27

Polyunsaturated Fatty Acids and Atrial Fibrillation: Friend or Foe? 2026-07-02

A Case of Familial Chylomicronemia Syndrome Caused by a Novel Homozygous GPIHBP1 Mutation Successfully Treated with the Selective PPARα Modulator Pemafibrate 2026-06-16